Postponed to 2021





Benelux Pharmacovigilance Day

Benelux Pharmacovigilance Day

Considering the international emergency due to COVID-19, the Benelux Pharmacovigilance Conference will be postponed to 2021.

The new date will be available soon.

“Safety and Pharmacovigilance” increasing Awareness of Significant and Essential Needs in Benelux Countries 

The 4th Benelux Pharmacovigilance Day conference will be the opportunity to discuss, deliberate and debate the latest operational and technological challenges in the Pharmacovigilance (PV) and drug safety field. Recent advances and perspectives in PV and drug safety in clinical trials will be shared during the meeting, with an emphasis on practical aspects and how-to. This event brings together the relevant experts to share their experience in the field using practical examples. This will trigger engaging discussions and will guide participants’ efforts in the jungle of currently available methods. The objective is to help find solutions to multiple challenges that, as a cross-functional development team in PV, must solve to maximize new opportunities ahead. 

This year’s event focuses on hot topics that have major impact on Safety and Pharmacovigilance related processes and activities such as, but not limited to:

  • New inspection mood and audit feedback (PV quality compliance linked to new AI tools)
  • New medical device regulation: Impact on safety reporting
  • Safety reporting in drug-device combination  
  • AI in Literature monitoring, new tools 
  • Assessment of effectiveness of risk Minimization Measures    
  • Big Data in PV- Signal management 
  • QPPV challenge & emerging trends linked to Brexit 
  • New PV tools, Machine learning and AI (data protection and Signal detection – requirements, challenges and compliance) how to capture safety concerns?
  • Clinical Trial regulation (CLINICAL TRIALS REGULATION (EU) NO 536/2014 Q&A document) 
  • PV requirements for health supplements or alternate therapies

During this one-day forum we will provide and discuss the best solutions to help drive success in your organization.

Scientific Board

Elena Prokofyeva – Head of Drug Safety Unit at FAMHP

Leanne Walsh - Global Director, Drug and Device Safety Services at Covance

Parminder Kaur - CEO & EU QPPV at RegPak BioPharma Consulting

Who should attend?

This conference is designed to benefit functional/technical professionals working in the pharmaceutical and health care area dealing with the Pharmacovigilance system, such as: Safety and Pharmacovigilance dept, Clinical operation dept, Statistic dept, Medical Affairs dept, Medical Information dept, Regulatory Affairs dept, Quality & Compliance dept, Legal dept, Software Developing dept, Medical Devices Manifacturing Companies, University Faculties scientists who are related to clinical and medical research (Senior, Associate and Assistant Professors, Research Scholars, Phd students). Also, Directors/Seniors Directors/Executive Directors and Vice Presidents /Senior Vice Presidents/Executive Vice Presidents and Heads/Leaders/Partners of: CROs and CMOs, Clinical Research Sites, Pharma, Biotech and Medical Devices Industries.


For sponsorship opportunities, please contact

Conference Price

805.00 €

Early Bird

Wednesday, June 30, 2021

685.00 €

Payments accepted

  • Bank Transfer
  • Credit Card
  • PayPal

For information:


Francesca Archetti
Francesca Archetti Operations & Training Manager
Annalisa De Biasi
Annalisa De Biasi Project & Scientific Manager
Enrico Pedroni
Enrico Pedroni Managing Director
Organised by

Technical and scientific training in the
pharmaceutical field
Via Roma 20 – 24022 – Alzano Lombardo (BG)
Tel: +39 035 515684

Participants' Feedbacks

Interaction during breaks is always very interesting. Presentations are clear

Very effective speakers. Good food, good location 

Met colleagues from the industry.  Heard from (new) develpments

Good Program .The combined presentations gave a good insight in current PV 

Different aspect of PV were addressed. Good diversity of speakers and background

In each topic there was some relevance to my daily work

Very well selectioned topics, presenters are experts in the area 

Perfect opportunity to have "hot topics" to discuss outside the"own environnment". Opportunity to have several topics discussing in just one day 

Good organization. Good networking possibilities

Variety of topics adressed / competency of speakers 

Very nice group!

LS Academy by numbers

Active since
Trained Professionals

Group Rates

Contact us to register more people to benefit from the best discount

Secure payment with

Customer service

Monday - Friday: 9:00 | 13:00 and 14:00 | 18:00
+39.(0)35.515684 -

Close Menu


Benelux Pharmacovigilance Day

information request

Benelux Pharmacovigilance Day

Sponsorship request

Terms & Conditions

The fee includes: tuition, teaching materials, lunches and coffee breaks, organizational office assistance, attendance certificate. Early Bird discount not applicable to Freelance – Academy – Public Administration fee.
The course will proceed with a minimum of 8 participants. Should this number not be reached the registered participants will be notified one week prior to the commencement of the course.
For further information please contact:  e-mail:  telephone: +39 (0)35.515684

The fee includes: seat at the conference, copy of presentations of Speakers who allow the distribution, informative literature for the day, networking lunch, coffee break, organisational office assistance, certificate of attendance. For further information please contact:  e-mail:  telephone: +39 (0)35.515684

The fee includes: tuition, teaching materials, organizational office assistance, attendance certificate. Early Bird discount not applicable to Freelance – Academy – Public Administration fee. For further information please contact:  e-mail:  telephone: +39 (0)35.515684

Common Terms & Conditions

Terms of payment
Payment should be made online (by credit card) or by bank transfer, at the time of registration (only for Italian companies: + 22% VAT) to EasyB s.r.l by bank transfer or by credit card. Bank transfer payable to:

EasyB S.r.l.
Via Roma, 20 – 24022 Alzano Lombardo (Bergamo)
VAT: IT03633040161
BANCO BPM – Filiale di Carobbio degli Angeli
IBAN: IT81 F 05034 53960 000000003450

Confirmation of event admission will be given on receipt of payment. Invoice will be sent following receipt of payment. EasyB reserves the right to refuse late registrations or additional registrations above the maximum accepted number of participants or registrations of roles that are not included in the target of the event.

Please note that refunds (50% refund of the registration fee) will only be given if cancellation is received at least four weeks before the event date. Cancellations will only be valid if made in writing. Transfer of registrations (or name changes) are allowed for free and should be made in writing within 7 days prior to the event. EasyB reserves the right to postpone or cancel an event, to change the location of an event or to alter the advertised speakers for an event, to change its performance from residential to webinar/online. EasyB is not responsible for any loss or damage as a result of substitution, alteration, postponement or cancellation of an event due to causes beyond its control including without limitation, acts of God, natural disasters, sabotage, accident, trade of industrial disputes, terrorism, hostilities, epidemics, pandemics, and / or authorities’restrictions (so-called factum principis).

Information collection and use
In accordance with the Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016, we inform you that EasyB S.r.l. (with headquarter in Via Roma 20, Alzano Lombardo, Bergamo, Italy, VAT number IT03633040161), as the data controller, will use your personal data voluntarily provided by you only with the consent and in compliance with the principles dictated by the European Regulations on the protection of personal data for, for the management of participation in the course, for sending the newsletter, and for dissemination purposes. You can read the complete information, including your rights and how to exercise them, following this link.